Quantcast

Latest Heart failure Stories

2014-08-06 23:11:43

According to the Centers for Medicare & Medicaid Services (CMS), cardiac rehabilitation provides benefit for people living with congestive heart failure (CHF), as well as for men and women following cardiac surgery or interventional cardiology procedures. Dignity Health St. Mary Medical Center in Long Beach recently upgraded its Cardiac Rehabilitation Unit to better accommodate patients. Long Beach, CA (PRWEB) August 06, 2014 A good workout experience is important to patients like...

2014-08-05 08:35:27

FRAMINGHAM, Mass., Aug. 5, 2014 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the Canaccord Genuity 34th Annual Growth Conference at 9:00 a.m. EDT on Thursday, August 14, 2014. The conference is being held August 13-14 at the InterContinental Boston. A...

2014-07-31 08:37:20

Doctors at Virginia Commonwealth University Medical Center discuss the benefits and use of the SynCardia Total Artificial Heart in a PubMed-indexed case report and video that includes implant surgery of 60-year-old man. TUCSON, Ariz., July 31, 2014 /PRNewswire/ -- For the first time, cardiac surgeons, medical professionals and the public can watch the implantation of the SynCardia temporary Total Artificial Heart in a peer reviewed case report paper and matching video posted on the...

2014-07-28 08:29:32

-- Next-generation HNO prodrug targeting severe heart failure was well tolerated and showed hemodynamic activity in a Phase I clinical trial -- CHAPEL HILL, N.C., July 28, 2014 /PRNewswire/ -- Cardioxyl Pharmaceuticals, Inc. announced today the positive results of a clinical trial demonstrating that CXL-1427, a novel potential treatment for acute decompensated heart failure (ADHF), was well tolerated in healthy volunteers. The company has now initiated dosing of hospitalized...

2014-07-23 23:26:50

EECP Treatment is FDA-Cleared for Refractory Angina and Offered at Dr. Weaver’s EECP Independent Outpatient Facility in the U.S. Los Angeles, CA (PRWEB) July 22, 2014 Ronald S. Weaver, MD, owner of Global Cardio Care Centers in Inglewood, Calif., today announced a heart transplant patient with cardiomyopathy has successfully completed a course of Enhanced External Counterpulsation (EECP) therapy at Global Cardio Care Centers and is no longer a candidate for heart transplant. The...

2014-07-23 12:30:34

CLEVELAND, July 23, 2014 /PRNewswire-USNewswire/ -- Juventas Therapeutics, a clinical-stage biotechnology company developing a first-in-class regenerative gene therapy for treatment of heart failure announced adding two industry veterans to its leadership team. Dale Sander has joined as Chief Financial Officer. Dr. Francis Plat will serve in an advisory capacity as Chief Strategy Officer. http://photos.prnewswire.com/prnvar/20131028/DC04442LOGO Mr. Sander has more than 20 years of...

2014-07-23 08:27:25

LONDON, July 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Cardiac Biomarkers: Technologies and Global Marketshttps://www.reportbuyer.com/product/2070047/Cardiac-Biomarkers-Technologies-and-Global-Markets.html REPORT HIGHLIGHTSThe global market for in vitro diagnostic tests for cardiac biomarkers was estimated at $3.1 billion in 2012 and nearly $4 billion in 2013. This market is predicted to reach $7.2 billion by 2018, at a compound annual growth...

2014-07-22 12:29:46

Ronald Fontana is discharged home while he waits for a matching donor heart transplant. He is enjoying his family, thanks to the SynCardia Total Artificial Heart powered by the Freedom Portable Driver. TUCSON, Ariz., July 22, 2014 /PRNewswire/ -- A central New York recipient of a SynCardia temporary Total Artificial Heart implant is home, discharged from University of Rochester's Strong Memorial Hospital with the Freedom® portable driver to wait for a matching donor heart....

2014-07-16 12:27:35

Now the Freedom® portable driver is available to all clinically stable SynCardia Total Artificial Heart patients in the US so they can be discharged from the hospital to enjoy life with family while waiting for their donor hearts. TUCSON, Ariz., July 16, 2014 /PRNewswire/ -- The Freedom® portable driver received FDA approval on June 26, 2014 for use with the SynCardia temporary Total Artificial Heart as a bridge to transplantation in cardiac transplant candidates who are clinically...

2014-07-15 10:29:05

BMJ-British Medical Journal Inability to register surprise strongest indicator; can help prioritize care, say doctors Patients with serious heart and lung conditions don't have the normal range of facial expressions, particularly the ability to register surprise in response to emotional cues, finds preliminary research published online in Emergency Medicine Journal. This finding could be used to help busy emergency care doctors decide whom to prioritize for treatment, and gauge who...


Latest Heart failure Reference Libraries

Circulation (journal)
2012-06-04 14:21:01

Circulation is a scientific journal published by Lippincott Williams & Wilkins on behalf of the American Heart Association. In 2008 the journal added six subspecialty publications: Circulation: Arrhythmia and Electrophysiology, Circulation: Heart Failure, Circulation: Cardiovascular Imaging, Circulation: Cardiovascular Interventions, Circulation: Cardiovascular Quality and Outcomes, and Circulation: Cardiovascular Genetics. Circulation publishes articles related to research in and the...

More Articles (1 articles) »
Word of the Day
barghest
  • A goblin in English folklore, often appearing in the shape of a large dog and believed to portend imminent death or misfortune.
  • A ghost, wraith, hobgoblin, elf, or spirit.
The origin of 'barghest' is not known, but it may be from perhaps burh-ghest, town-ghost, or German Berg-geist (mountain spirit) or Bär-geist (bear-spirit).
Related